JCS speaks with Craig Brown of Dora Wirth (Languages) Ltd, on steps companies can take to avoid faulty translations The language used in clinical trial …

Since the beginning of the COVID-19 public health emergency, the FDA has been working to facilitate the development and availability of medical products and equipment …

Pharmaceutical companies, transportation providers, clinical customers and packaging vendors are increasingly focusing on the environmental impact associated with conducting clinical trials or the transportation or …

The fundamental responsibility of Data Management teams in clinical trials is to ensure the collection of accurate data needed as per study protocol requirements. Deepu …

Good Clinical Practice (GCP) provides an internationally accepted standard to ensure subject safety and data integrity in clinical trials incorporating ethical and scientific guidelines. Amer …

Chronic and post-surgical pain that opioids are intended to alleviate have been offset by a host of societal pains stemming from the prevalence of opioid …

Volunteer infection studies or controlled human infection models (CHIMs) are an extremely effective way to gather early clinical evidence on a new drug or vaccine’s …

The susceptibility to and the outcomes of COVID-19 are strongly associated with the presence of CV risk factors and with established CV disease. Clinical trials …

The novel coronavirus disease (COVID-19) pandemic has impacted global economies. These disruptions, also experienced by the global industry-sponsored research (ISR) industry, required new guidelines and …

In the pharmaceutical industry, about one-third of all drugs in the pipeline of the top ten pharmaceutical companies were initially developed elsewhere. Sponsor companies have …